(CNTO), Malvern, Penn.
Oppenheimer & Co. analyst Matthew Geller said cardiologists were disappointed that although
reduced the incidence of death of heart attack at six
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury